TransCode Therapeutics, Inc.
RNAZ
$8.95
-$0.34-3.66%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 51.18% | 119.84% | 135.45% | 109.97% | -74.83% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -10.05% | -7.44% | -33.38% | -37.50% | -36.96% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.76% | -35.74% | -36.52% | -17.56% | 11.71% |
| Total Current Assets | 31.51% | 87.89% | 94.29% | 59.21% | -61.46% |
|
|
|||||
| Total Current Assets | 31.51% | 87.89% | 94.29% | 59.21% | -61.46% |
| Net Property, Plant & Equipment | -90.60% | -92.43% | -91.80% | -85.18% | -71.49% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 307.24% | -- | 0.00% | 0.00% | 0.00% |
| Total Assets | 32.79% | 71.34% | 80.98% | 41.10% | -61.52% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 39.24% | -52.22% | 6.04% | -11.25% | -58.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -90.71% | -62.34% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -6.27% | -- |
| Total Other Current Liabilities | -- | -- | -- | -6.27% | -- |
| Total Current Liabilities | 29.94% | -55.32% | -7.26% | -20.59% | -59.20% |
|
|
|||||
| Total Current Liabilities | 29.94% | -55.32% | -7.26% | -20.59% | -59.20% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 66.41% | -39.51% | 7.22% | 163.91% | -60.54% |
|
|
|||||
| Common Stock & APIC | 45.73% | 52.36% | 57.53% | 27.31% | 25.95% |
| Retained Earnings | -47.44% | -44.84% | -51.35% | -36.16% | -35.26% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -13.69% | 364.92% | 124.52% | -223.03% | -62.79% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -13.69% | 364.92% | 124.52% | -223.03% | -62.79% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -13.69% | 364.92% | 124.52% | -223.03% | -62.79% |
|
|
|||||